As median survival increases among patients with CF, clinicians must now be aware of previously uncommon comorbidities emerging as this patient population ages.
New Cystic Fibrosis Medication May Be a Game Changer
Clinical trials of TRIKAFTA demonstrated robust improvement in pulmonary function in patients with cystic fibrosis. In this article, pediatric pulmonologist Nathan Kraynack, MD, shares his early experience with the new, game-changing regimen.